Ovulatory Dysfunction and Infertility Flashcards
evaluation of oligo/amenorrhea: initial tests
hCG, baseline FSH and estradiol
evaluation of oligo/amenorrhea: what test should you order if low or normal FSH?
progestin challenge to assess estrogenization of uterine lining
when should you order a progestin challenge?
if patient is experiencing oligo/amenorrhea and has low/normal FSH
what is the basis of the progestin challenge?
in order to have bleeding after progesterone administration, patient needs to have been exposed to estradiol because estradiol induces expression of progesterone receptors
criteria for polycystic ovarian syndrome (PCOS)
two of three features:
- polycystic-like ovaries on ultrasound
- oligomenorrhea
- hyperandrogenism (hirsutism)
first-line treatments for ovulation induction in polycystic ovarian syndrome (PCOS)
weight loss, clomiphene citrate
clomiphene citrate: mechanism of action, use
reduces concentration of intracellular estrogen receptors –> diminished negative feedback –> activates GnRH secretion –> ovulation
use: first-line treatment for ovulation induction in polycystic ovarian syndrome (PCOS)
potential reasons for lack of withdrawal bleeding in response to progesterone therapy
- lack of circulating estradiol resulting in inadequate endometrial proliferation
- severe endometrial adhesions (Asherman’s syndrome)
- pregnancy
ddx: low/normal FSH and low estradiol
hypogonadotropic hypogonadism: absence of sellar mass, Kallman’s syndrome, GnRH receptor mutations
Asherman’s syndrome: pathogenesis
intrauterine adhesions resulting from procedures that damage the endometrial cavity; can cause secondary amenorrhea and lack of withdrawal bleed in response to progesterone
premature ovarian failure: pathogenesis, clinical presentation, lab findings
premature atresia of ovarian follicles in women of reproductive age
present with signs of menopause after puberty but before age 40
decreased estrogen, increased LH and FSH (HYPERgonadotropic hypogonadism)
causes of premature ovarian failure
genetic (Turner’s syndrome, Fragile X), autoimmune, iatrogenic (chemo, radiation)
risk factors for tubal disease
history of pelvic infections, tubal or pelvic surgery, endometriosis
steps of IVF
- ovarian stimulation with injectable gonadotropins (FSH, FSH/LH)
- oocyte retrieval
- fertilization
- embryo transfer
expected diagnosis, lab findings, and response to progestin challenge: marathon runner with infertility
hypothalamic amenorrhea: low estradiol, low/normal FSH; no withdrawal bleed with progestin challenge